Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
AssigneeMerck Sharp & Dohme Corp.
InventorsChristopher J. Swain, Martin R. Teall, Brian J. Williams
Life of this patent
Estimating the term…
Loading patent…
AssigneeMerck Sharp & Dohme Corp.
InventorsChristopher J. Swain, Martin R. Teall, Brian J. Williams
Estimating the term…
Compounds of formula (I), and salts and prodrugs thereof, wherein Q is R.sup.9 CR.sup.10 R.sup.11 or CH.sub.2 R.sup.9 CR.sup.10 R.sup.11 where R.sup.9 is H or OH and R.sup.10 and R.sup.11 are optionally substituted phenyl, optionally substituted benzyl, C.sub.5-7 cycoalkyl or (C.sub.5-7 cycloalkyl)methyl; R.sup.1 and R.sup.2 are H, optionally substituted C.sub.1-6 alkyl, optionally substituted phenyl(C.sub.1-4 alkyl), C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, COR.sup.a, COOR.sup.a, COC.sub.1-6 alkylhalo, COC.sub.1-6 alkylNR.sup.a R.sup.b, CONR.sup.12 C.sub.1-6 alkylCONR.sup.a R.sup.b, CONR.sup.a R.sup.b, or SO.sub.2 R.sup.a, or R.sup.1 and R.sup.2 together form a chain (CH.sub.2).sub.q optionally substituted by oxo where one methylene group may optionally be replaced by O or NR.sup.x ; R.sup.3 is H, C.sub.1-6 alkyl or C.sub.2-6 alkenyl; R.sup.4 is optionally substituted phenyl(C.sub.1-3 alkyl); X and Y are H, or X and Y together are .dbd.O; and Z is O, S, or NR.sup.7 ; are tachykinin antagonists. They and compositions thereof are useful in therapy.
A compound of formula (I), or a pharmaceutically acceptable salt or prodrug thereof:
A compound selected from
A compound selected from(2S)-1-((3,5-bis(trifluoromethyl)phenyl)methyloxy)-2-((N-((methylcarbo xamido)methyl)-N-methyl)amino)-3,3-diphenylpropane;
Dependencies are inferred from the claim text.